Protocol Risk Assessment is the starting point for any RBQM approach. How do you design a monitoring strategy to align with the risk assessment, and then how does the ongoing management of risk impact when, where, what and how you monitor? These are practical, operation challenges which go beyond a basic understanding of regulatory guidance, and are the real-world challenges being faced by those companies who are now adopting a true RBQM approach to clinical trials.
In this free webinar, COO Tammy Finnigan will show you the key steps in developing your monitoring strategy and how to deal with the ongoing challenges of managing risks.
Please click here to book your place (please note places are limited).